MBRX icon

Moleculin Biotech
MBRX

Overview Fund Trends Analyst Outlook Journalist POV

17 hedge funds and large institutions have $918K invested in Moleculin Biotech in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$288K
2
+$274K
3
+$117K
4
TSS
Two Sigma Securities
New York
+$28K
5
Truist Financial
Truist Financial
North Carolina
+$23.5K

Top Sellers

1
-$17K
2
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$309K
2
$274K
3
$117K
4
$47K
5
$29K
6
$28K
7
$21K
8
$20K
9
$20K
10
$13K
11
$13K
12
$12K
13
$7K
14
$4K
15
$3K
16
$1K
17
–
18
–